Evidence map›Paper›PMID 42101344›Full record

ArticleVox sanguinis2026

Molecular characterization of D variants in Brazilian blood donors and their association with RhCE and Duffy phenotypes.

Thamy C S Silva, Marcia R Dezan, Sidneia Costa, Beatriz C Girardo, Bruno R Cruz, Karen Ziza, Dante M Langhi, José O Bordin, Lilian Castilho, Carla L Dinardo

Abstract read
In one paragraph

Article in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thamy C S SilvaDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0009-0000-6434-1654
Marcia R DezanFundação Pró-Sangue, São Paulo, Brazil.
Sidneia CostaDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Beatriz C GirardoDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Bruno R CruzDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Karen ZizaDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Dante M LanghiDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-4642-8091
José O BordinDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Lilian CastilhoRed Cell and Molecular Blood Group Laboratory, Hemocentro-UNICAMP, Campinas, São Paulo, Brazil.
Carla L DinardoDepartment of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 156277/2019-0
6 · The paper itself

Abstract

BACKGROUND AND

objectivesSerological classification of RhD-negative and weak D is often insufficient in admixed populations, where diverse RHD variants have clinical implications. In Brazil's highly admixed population, RhD interpretation and donor-recipient matching are particularly challenging. We used Duffy phenotyping to support ancestry inference and contextualize Rh variants. Understanding RHD alleles and their associations with RhCE and Duffy is essential for transfusion safety. Here, we characterize RHD variants in Brazilian donors and relate them to RhCE and Duffy phenotypes across regions. MATERIALS AND

methodsWe analysed 321 blood donor samples with either weak D expression (n = 295) or a D-negative phenotype with C and/or E antigen positivity (n = 26). RhD, RhCE and Duffy phenotyping was performed, followed by RHD, RHCE and FY genotyping using multiplex polymerase chain reaction with sequence-specific primers (PCR, PCR-SSP) and real-time PCR. Samples unresolved by targeted assays underwent sequencing.

resultsAmong weak D donors, 88% carried known RHD variants, with weak D types 1, 2 and 3 accounting for 67% of cases. Partial D alleles such as DAR, DAU4 and weak partial 11 were identified, particularly among donors with Fy(a-b-) and Fy(a+b-) phenotypes, often associated with RHCE*733G. In the D-negative group, 50% of samples harboured non-functional or hybrid RHD alleles, including RHD*03N.01/RHD*08N.01 and RHD*08N.01/RHD*01N.01, linked to the r's haplotype and RHCE*ceS allele.

conclusionThis study reveals the wide spectrum of RHD variants in an admixed population and underscores the importance of integrating molecular genotyping and phenotype associations to improve transfusion safety and guide Rh immunoprophylaxis.

Indexed as

Blood DonorsDuffy Blood-Group SystemRh-Hr Blood-Group SystemAllelesBlood DonationBrazilFemaleGenetic VariationGenotypeHumansMalePhenotypeDuffy Blood-Group SystemRHCE protein, humanRh-Hr Blood-Group SystemRho(D) antigenadmixed populationD variantsgenotypingimmunohaematologyRHD

Identifiers

PMID42101344
PMCPMC13453919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.